Nortech Systems Inc. (NSYS) - Q2 2024 10-Q Summary
Business Context and Reporting Period
Nortech Systems Inc. is a global EMS contract manufacturer serving the Medical, Aerospace & Defense, and Industrial markets. This report covers the quarterly period ended June 30, 2024. The company operates facilities in Minnesota, Mexico, and China. In May 2024, management announced the closure of its Blue Earth, Minnesota facility by the end of 2024, with operations consolidating to the Bemidji facility.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | Q2 2023 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Net Sales | $33,891 | $35,021 | $68,106 | $69,909 |
| Gross Profit | $4,617 | $5,474 | $10,065 | $10,958 |
| Gross Margin | 13.6% | 15.6% | 14.8% | 15.7% |
| Operating Income | $344 | $1,099 | $1,499 | $2,152 |
| Net Income | $157 | $634 | $922 | $1,315 |
| Diluted EPS | $0.05 | $0.22 | $0.32 | $0.46 |
| Cash & Equivalents | $1,542 | - | - | - |
| Operating Cash Flow (YTD) | ($1,458) | $281 | - | - |
| Debt (Line of Credit) | $8,360 | - | - | - |
Note: All dollar amounts in thousands, except per share data.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 3.2% in Q2 and 2.6% YTD compared to 2023. The Medical segment drove the decline (-13.3% Q2, -11.9% YTD) due to customer inventory rebalancing and lower average sales prices. Conversely, Aerospace & Defense sales grew 23.9% Q2 and 29.3% YTD.
- Margin Compression: Gross margin decreased by 200 basis points in Q2 and 90 basis points YTD, attributed to lower net sales and reduced facility utilization.
- Restructuring Charges: The company incurred $91 in restructuring charges in Q2 and YTD 2024 related to the Blue Earth facility closure. No such charges were recorded in 2023.
- Cash Flow: Operating cash flow turned negative, using $1,458 YTD 2024 compared to providing $281 in the prior year. This was driven by increased inventory purchases for facility transitions and timing of accounts payable.
- Backlog: Total order backlog decreased 27.4% year-over-year to $73,296, reflecting normalized supply chain lead times and customer inventory rebalancing.
Guidance, Outlook, and Risks
- Facility Consolidation: The company expects to incur approximately $800 in total cash restructuring costs for 2024, substantially all of which are expected to be paid by December 2024.
- Financing: In February 2024, the company replaced its asset-backed line of credit with a $15,000 Senior Secured Revolving Line of Credit. As of June 30, 2024, $8,360 was outstanding with $6,440 unused availability. The company received a waiver for a covenant breach regarding operating expense contributions to Mexican operations.
- Outlook: Management notes reduced revenue visibility for the next several quarters as customers defer orders to rebalance inventories.
- Risks: Key risks include supply chain disruptions, loss of major customers (one customer represented 26% of Q2 sales), currency exchange volatility, and the successful execution of the facility consolidation.
- Accounting Correction: An out-of-period correction in Q1 2024 reduced net income by $178 due to an understatement of accrued liabilities in the prior year.
Investor Verification Checklist
- Medical Segment Recovery: Verify the timeline for customer inventory rebalancing to end and the impact of moving programs to the Monterrey, Mexico facility on pricing and margins.
- Restructuring Execution: Monitor the actual cash outflow for the Blue Earth facility closure against the $800 estimate and ensure no additional unexpected costs arise.
- Debt Covenants: Confirm continued compliance with the new Bank of America Revolver covenants, specifically regarding the Mexican operations expense waiver.
- Backlog Visibility: Assess whether the 27.4% year-over-year backlog decline stabilizes in Q3 as customer ordering patterns normalize.
- Related Party Transactions: Review the status of the $85 receivable from Abilitech Medical (owned by the Chairman) which has been fully reserved, and the progress of the BIRD Foundation grant with Marpe Technologies.